bpc 157 safety clinical trials Integrative Peptides BPC-157: complete guide to oral peptide supplements bpc-157 human clinical trials evidence
Description
This was defined as a 1-point to 2-point decline in the Revised ALS Functional Rating Scale (ALSFRS-R) total score over an initial three-month observational period
Her primary focus is on the molecular mechanisms of aging and neurodegenerative diseases, but she also has subject-matter expertise in cell biology, genetics, epigenetics, and psychology
Strong response suggests maintaining current dosing
BPC-157 has no sequence overlap with other gut peptides and works in extremely tiny doses (micrograms to nanograms in animal studies)
